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Nacional Mayor de San Marcos, Lima, Perú, 3 Centro Basico de Investigación en Demencia y enfermedades
desmielinizantes, Instituto Nacional de Ciencias Neurológicas, Lima, Perú, 4 Departamento de Medicina,
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Nacional de Ciencias Neurológicas, Lima, Perú, 6 Departamento de Medicina, Hospital Nacional Cayetano
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Stroke is the leading cause of neurological impairment in the South American Andean
region. However, the epidemiology of stroke in the region has been poorly characterized.
Methods
We conducted a staged three-phase population-based study applying a validated eight-
question neurological survey in 80 rural villages in Tumbes, northern Peru, then confirmed
presence or absence of stroke through a neurologist’s examination to estimate the preva-
lence of stroke.
Results
Our survey covered 90% of the population (22,278/24,854 individuals, mean age 30±21.28,
48.45% females), and prevalence of stroke was 7.05/1,000 inhabitants. After direct stan-
dardization to WHO’s world standard population, adjusted prevalence of stroke was 6.94/
1,000 inhabitants. Participants aged�85 years had higher stroke prevalence (>50/1000
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inhabitants) compared to other stratified ages, and some unusual cases of stroke were
found among individuals aged 25–34 years. The lowest age reported for a first stroke event
was 16.8 years. High blood pressure (aPR 4.2 [2.7–6.4], p>0.001), and sedentary lifestyle
(aPR 1.6 [1.0–2.6], p = 0.045) were more prevalent in people with stroke.
Conclusions
The age-standardized prevalence of stroke in this rural coastal Peruvian population was
slightly higher than previously reported in studies from surrounding rural South American
settings, but lower than in rural African and Asian regions. The death rate from stroke was
much higher than in industrialized and middle-income countries.
Introduction
Stroke is the leading cause of neurological impairment in South America’s Andean region,
which includes Bolivia, Colombia, Ecuador, Peru, and Venezuela [1]. Despite this significant
cerebrovascular disease burden, there is little information regarding stroke rates, mortality, or
associated risk factors in rural populations [2, 3].
The World Health Organization Monitoring Trends and Determinants in Cardiovascular
Disease (MONICA) project does not include stroke registry information for any country in
the Andean region [4]. In 1988, a population-based study conducted in Cuzco, Peru, showed
an age-adjusted prevalence of 5.74 per 1,000, [5] similar to Colombia (5.6/1,000), [3] but
slightly higher than Bolivia (3.22/1,000) [6]. Compared with other regions worldwide, Latin
America has higher proportions of patients with hemorrhagic stroke [7], small vessel disease
[2, 7, 8] and intracranial atherosclerotic lesions [9]. Additionally, the Andean sub-region pos-
sesses unique infectious risk factors, including Chagas’ disease, neurocysticercosis, malaria,
leptospirosis and viral hemorrhagic fevers, and non-infectious factors such as high altitude
hypoxia and snake bites [2–5, 10, 11].
Taking advantage of a prior population-based epidemiologic survey from a cysticercosis
elimination program in Tumbes, Peru, we applied a validated eight-question neurological sur-
vey to estimate stroke symptom prevalence, confirm presence of stroke through a standardized
neurologic examination, and evaluate stroke-associated risk factors in this region.
Materials and methods
Study population
We cross-sectionally surveyed 24,854 individuals from 80 communities from the cysticercosis
elimination program, living near sea-level along Peru’s Northern coast (Fig 1). The study area,
covering 4,669.2 km2, contains a mostly Mestizo population. Life Expectance in Peru from
2015–2020 was 76,26 years old. Most villages have electricity but lack sewage facilities or run-
ning water. The area has 28 basic-level health centers; each staffed by a recently-graduated gen-
eral practitioner (GP) performing a one-year rural service; one nurse and one health worker.
Activities were performed in three phases.
Phase I–Stroke survey
A baseline census was performed to obtain household-level information. After obtaining
informed consent (IC), non-medical field workers (trained by a team of neurologists)
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administered an eight-question face-to-face survey to identify stroke symptoms in all individu-
als older than 15 years. Illiterate individuals were included through reading aloud the IC and
survey to ensure understanding. This WHO stroke detection questionnaire was translated into
Spanish, modified, and validated by Del Brutto et al. in the Atahualpa Project. [12] Most older
individuals were living in a relative’s home.
Phase II–General practitioner evaluation
Participants reporting symptoms of stroke by responding yes to question 1 or 2, or a combina-
tion of two positive responses between questions 3 to 8, were evaluated in a local health center
by a GP trained by neurologists to recognize stroke and other conditions mimicking stroke.
Care was taken to include the local dialect to describe stroke, such as “derrame”. The evalua-
tion included anthropometric measures (weight, height, body mass index (BMI) calculated as
weight (kg) divided by squared height (m2) [13], abdominal circumference, and brachial cir-
cumference), as well as questions regarding history of high blood pressure, diabetes, dyslipide-
mia, cardiac disease, smoking, alcohol or illicit drug use, and amount of exercise. All
participants classified as “suspected stroke” were included in Phase III (neurological evaluation)
to confirm diagnosis of stroke.
Phase III—Neurological examination, blood testing and brain
computerized tomography (CT) scan
A team of board-certified neurologists evaluated suspected stroke cases for case-confirmation
and to rule out non-stroke events. Stroke was defined according to WHO criteria, as “rapid
development of clinical signs of focal (or global) disturbance of cerebral functions, lasting>24
hours, with no apparent cause other than vascular” [6, 12, 14–16]. Non-contrast brain CT scans
were offered to all participants with a suspected diagnosis of stroke and performed using a heli-
coid CT scan (Siemens AG, Germany) in the Center for Global Health facility. Reproductive-
aged women had a urine pregnancy test performed prior to imaging, and pregnant women did
not undergo brain CT.
Fig 1. Map of 80 rural communities in Tumbes involved in the study.
https://doi.org/10.1371/journal.pone.0254440.g001
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Venous blood samples (8ml) were collected from stroke cases to assess: fasting blood glu-
cose (FBG), glycosylated hemoglobin (HbA1c), serum lipid profiles including total cholesterol
(TC), triglyceride (TG), The total cholesterol/HDL cholesterol ratio (American Heart Associa-
tion [AHA] [17] target below 5 in males, and below 4.4 in females), the LDL cholesterol/HDL
cholesterol ratios (AHA target below 3.5 in males, and below 3.2 in females) [17] and
hematocrit.
Hypertension was defined as mean systolic blood pressure (SBP)�140mmHg or mean dia-
stolic blood pressure (DBP)�90mmHg [13], diabetes mellitus (DM) was diagnosed as FBG
�126 mg/dl or HbA1c�6.5% [18] and/or self-reported diagnosis during the GP evaluation.
Heart disease history was self-reported during the GP evaluation. Participants were asked
whether they regularly used tobacco (current smoking defined as�1 cigarette/day) [13], con-
sumed alcohol (any alcoholic drink in the last week), sedentary lifestyle (office work, driving as
a chauffeur, and sitting while watching television or low physical activities) [19].
Ethical considerations
The study protocol and consent forms were approved by the institutional review boards of
Universidad Peruana Cayetano Heredia, the University of Washington and the Regional
Directorate of the Ministry of Health (DIRESA) in Tumbes.
Statistical analysis
Prevalence of stroke was defined as number of persons with confirmed stroke divided by num-
ber of baseline survey respondents. Age-adjusted stroke prevalence was obtained by dividing
the number of people with stroke in each age bracket by the number of individuals in the same
age bracket as stratified in the World (WHO 2000–2025) standard population. Incidence was
defined as number of persons who developed stroke in the year preceding the prevalence day
(April 5, 2011), divided by total number of study participants. The world (WHO 2000–2025)
standard population census was the reference population for prevalence age adjustments. Con-
fidence intervals were estimated using exact binomial method. Prevalence ratios (PR) and
adjusted PR (aPR) were estimated using Poisson family general linear models with logit link.
All reported probability (p) values were two-sided with significance level set at 0.05. Variables
significant at the level of p<0.25 were retained in the multivariable models from which
adjusted odds ratios were estimated. All-cause mortality was defined as total number of deaths
during the study period (between phase I and III; April 2011-May 2012), divided by partici-
pant population. We used Stata version 14.2 for statistical analysis (Stata Corp., College Sta-
tion, TX, USA).
Results
From a population of 34,825 people across 80 rural communities, 24,854 individuals older
than 15 years were invited to participate; 22,278 (89.63%) individuals provided informed con-
sent and completed the eight-question stroke survey. The participants most frequently lived in
hand-constructed mud and cane houses, had public potable water service that was functional
for a few hours each day, treated water with chlorine pills, and defecated in holes/silos;
although a sizable proportion (24.2%) reported open field defecation.
Comparison between participants and non-participants
Compared to study participants, a larger proportion of non-participants were male (1,891/
2,577 [73.4%] vs 11,074/22,278 [49.7%]; p<0.0001); slightly younger (37.1 ± 17.2 vs
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39.9 ± 17.9; p<0. 0001); and lived in multi-family households (564/2,577 [21.9%] versus 3,937/
22,278 [17.7%]; p<0.0001). There were no differences in urbanicity, housing material, water
sources, drinking water, bathroom, and electricity between groups.
Comparison between positive and negative survey respondents
The proportion of positive respondents to the survey was 7.1% (1,586/22,278). Positive respon-
dents were more frequently female (920/1,586 [58.0%] vs 10,284/20,692 [49.7%]; p<0,0001),
older (mean age 47.9 ± 19.1 years vs. 39.3 ± 17.6 years; p<0,0001), and used latrines in a
slightly higher proportion (1,270/1,586 [80.1%] vs 16,038/20,692 [77.5%], p = 0,019) than neg-
ative respondents. The groups were similar in relation to housing material, household, water
sources, drinking water and electricity (Table 1).
Table 1. Demographic characteristics of respondent’s vs non-respondents and between negative and positive individuals surveyed for stroke.









Number % Number % Number % Number %
Sex
Female 686 26.6 11,204 50.3 <0,0001 10,284 49.7 920 58.0 <0,0001
Male 1,891 73.4 11,074 49.7 10,408 50.3 666 42.0
Age a
Mean + sd (IC) b 37,8 ± 17,2 37,1–38,5 39,9 ± 17,9 39,7–40,2 <0,0001 39,3 ± 17,6 39,1–39,6 47,9 ± 19,1 46,9–48,8 <0,0001
Urbanity
Marginal Urban 235 9.1 2,034 9.1 = 0,985 1,907 9.2 127 8.0 = 0,107
Rural 2,342 90.9 20,244 90.9 18,785 90.8 1,459 92.0
Material of Housing
Brick and others 435 16.9 4,066 18.2 = 0,087 3,803 18.4 263 16.6 = 0,074
mud and cane 2,142 83.1 18,212 81.8 16,889 81.6 1,323 83.4
Housing condition
Own home 2,488 96.5 21,191 95.1 = 0,005 19,666 95.0 1,525 96.2 = 0,137
Rent 46 1.8 537 2.4 506 2.5 31 1.9
Other 43 1.7 550 2.5 520 2.5 30 1.9
Household
Singlefamily 2,013 78.1 18,341 82.3 <0,0001 17,052 82.4 1,289 81.3 = 0,253
Multifamily 564 21.9 3,937 17.7 3,640 17.6 297 18.7
Source of water
Public service 2,131 82.7 18,752 84.2 = 0,052 17,438 84.3 1,314 82.8 = 0,134
Non public service 446 17.3 3,526 15.8 3,254 15.7 272 17.2
Drinking Water
Artesanal Treatment 2,066 80.2 17,672 79.3 = 0,315 16,425 79.4 1,247 78.4 = 0.046
Untreated 511 19.8 4,606 20.7 4,267 20.6 339 21.6
Bathroom
Bath 472 18.3 3,759 16.9 = 0,079 3,467 16.8 292 18.4 = 0,031
Latrine 1,568 60.9 13,549 60.8 12,571 60.7 978 61.7
Did not have 537 20.8 4,970 22.3 4,654 22.5 316 19.9
Electricity
On electric grid 2,388 92.7 20,643 92.7 = 0,993 19,193 92.8 1,450 91.4 = 0,050
no electricity 189 7.3 1,635 7.3 1,499 7.2 136 8.6
a mean and standard deviation
b p- value were calculated using Student’s t test
https://doi.org/10.1371/journal.pone.0254440.t001
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Prevalence of stroke survival
A total of 1,420 individuals were evaluated by a study physician (including two negative survey
respondents self-referred by study physicians due to symptoms compatible with stroke). We
classified these 318/1,420 (2.2%) as “suspected of stroke”, and 1,102 had a diagnosis other than
stroke (Fig 2).
Of the 318 participants with suspected stroke, 24 (7.5%) declined the neurologist evaluation,
137 had a diagnosis other than stroke, and 157 individuals were confirmed as having had a
stroke event. Stroke survival prevalence was 7.05/1,000 (157/22,278) inhabitants. After direct
standardization to WHO’s world standard population, the adjusted prevalence of stroke was
6.94/1,000 inhabitants. Participants aged 85 years and older had much higher prevalence
(>50/1,000 inhabitants) compared with other stratified ages, and some unusual cases were
found in individuals aged 25–34 years (Fig 3). Crude prevalence was similar for men and
women (81/11,204, 7.23 per 1,000 men vs 76/11,074, 6.86 per 1,000 women; p = 0.636)
(Table 2).
The youngest age reported for first-stroke event was 16.8 years; mean age at first event was
58.9 ± 16.5 years (mean ± SD), median 63 years, and interquartile range [IQR] 47.5–78.5
years. In age groups, first-stroke events were between 15 and 25 in 5 (3.9%), between 26 and 35
years in 10 (6.5%), between 36 and 45 years in 18 (11.6%), between 46 and 55 years in 30
(19.4%), between 56 and 65 years in 28 (18.1%), between 66 and 75 years in 39 (25.2%),
between 76 and 85 years in 21 (13.5%), and after 85 years in 3 (1.9%). Two people with stroke
(PWS) did not remember the date of their stroke event. Fifteen PWS (9.8%) had a history of
second stroke event and three (2.0%) had a history of third event.
All-cause mortality
Ninety-five study participants died between phases I and III (426.42 /100,000 population per
year). Of these 95 deaths, 25 were people classified as “suspected stroke” (25/1586, [1.6%]); 4 in
positive survey respondents, but not suspected of stroke (4/1266, [0.3%]), and 66 in negative
Fig 2. Study flowchart.
https://doi.org/10.1371/journal.pone.0254440.g002
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survey respondents (66/20,692, [0.3%]). The corresponding death rates were 1,576/100,000
population per year in people suspected of stroke and 316/100,000 population per year in the
other two groups (p< 0.0001).
Other neurological conditions
Other relevant neurological diagnoses in non-stroke cases included epilepsy in 84 participants,
Bell’s palsy in 152 participants, transient ischemic attack (TIA) in 37 participants, 2 cases with
sequelae of Guillain-Barre, and 2 cases of amyotrophic lateral sclerosis.
Retrospective stroke incidence
Eighteen stroke events occurred in the year before the survey, for a crude annual incidence
rate of 80.80 per 100,000 person/years. The incidence rate adjusted to 2007 census age distribu-
tion [20] was 129.72 per 100,000 person/years.
Clinical sub-types of stroke and brain CT findings
From the 157 PWS, clinical history of ischemic stroke was found in 139 (88.5%; 66 females
and 73 males, mean age 66, median age 68, range of time-lapse of event between 0–49 years,
average 7.10 years) and hemorrhagic stroke in 21 (11.6%; 12 females and 9 males, mean age 63,
median age 61, range of time-lapse of event between 1–25 years, average 9.33 years). Three
(1.9%) individuals with ischemic stroke later developed hemorrhagic stroke.
Non-contrast brain CT scan [21] was obtained in 132 PWS, 116 (87%) of whom had a
ischemic stroke diagnosis and 16 (23%) hemorrhagic stroke. Encephalomalacia was found in
59 (44.4%; [50/59 individuals with ischemic stroke]), atrophy with associated leukoencephalo-
pathy [22] in 28 (21.1%; [24/28 individuals with ischemic stroke]) and normal findings in 18
(13.5%; all with ischemic stroke).
Morbidity and characteristics of PWS
Differences in self-reported cardiovascular information between PWS (n = 157) and people
without stroke (PWOS, n = 1,102) included non-modifiable factors such as gender and age,
Fig 3. Prevalence of stroke and confidence interval stratified by age in 80 rural communities.
https://doi.org/10.1371/journal.pone.0254440.g003
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with PWS more frequently male (81/157[52.3%] vs 424/1,102 [38.5%], p = 0.002), and older
(65.5±15.7 vs 45.6±18.1 years, p = 0.0001). Modifiable factors such as high blood pressure, dia-
betes, dyslipidemia, history of heart disease, tobacco use, and sedentary lifestyle differed signif-
icantly between PWS and PWOS (Table 3): in an age- and sex-adjusted model, both high
blood pressure (aPR 4.2 [2.7–6.4], p>0.001), and sedentary lifestyle (aPR 1.6 [1.0–2.6],
p = 0.045), were significantly more prevalent in PWS (Table 3).
Table 3. Self reported information about cardiovascular health between stroke cases and non-stroke cases.




Crude model Adjusted model b
Prevalence Ratio p-value a Adjusted Prevalence Ratio p-value a
Sex
Female 678 61.52 76 48.41 Ref. Ref. Ref. Ref
Male 424 38.48 81 51.59 1,591 (1,188–2,131) = 0,002 1,429 (0,972–2,101) = 0,070
Age b
Mean + standard deviation 45,0 ± 18,2 65,5 ± 15,7 1,046 (1,039–1,053) <0,0001 1,028 (1,017–1,039) <0,0001
Self-reporting information
Hypertension
Absent 867 78.7 38 24.2 Ref. Ref. Ref. Ref
Present 235 21.3 119 75.8 8,006 (5,676–11,292) <0,0001 4,221 (2,775–6,421) <0,0001
Body mass index
Normal 433 39.3 53 33.8 Ref. Ref. Ref. Ref
Underweight 17 1.5 5 3.2 2,084 (0,926–4,691) = 0,076 1,512 (0,596–3,845) = 0,383
Overweight 434 39.4 69 43.9 1,258 (0,899–1,759) = 0,180 1,161 (0,805–1,674) = 0,424
Obese 218 19.8 30 19.1 1,109 (0,728–1,690) = 0,629 1,115 (0,691–1,801) = 0,655
Diabetes Mellitus
Absent 1,035 93.9 138 87.9 Ref. Ref.
Present 67 6.1 19 12.1 1,878 (1,226–2,877) = 0,004 1,126 (0,679–1,866) = 0,646
Dislipidemia
Absent 907 82.3 102 65.0 Ref. Ref.
Present 195 17.7 55 35.0 2,176 (1,617–2,929) <0,0001 1,210 (0,844–1,735) = 0,300
Heart Disease
Absent 1,080 98.0 148 94.3 Ref. Ref.
Present 22 2.0 9 5.7 2,409 (1,361–4,263) = 0,003 1,096 (0,550–2,185) = 0,795
Tobacco use
None 710 64.4 82 52.2 Ref. Ref.
Yes 392 35.6 75 47.8 1,551 (1,159–2,076) = 0,003 1,221 (0,825–1,807) = 0,318
Alcohol consumption
None 244 22.1 34 21.7 Ref. Ref.
Yes 858 77.9 123 78.3 1,025 (0,718–1,463) = 0,891 0,836 (0,544–1,285) = 0,414
Consumption of drugs
None 1,082 98.2 152 96.8 Ref. Ref.
Yes 20 1.8 5 3.2 1,624 (0,731–3,606) = 0,234 1,055 (0,425–2,616) = 0,908
Regular exercise
Yes 304 28.3 19 12.1 Ref. Ref.
None 798 71.7 138 87.9 2,506 (1,578–3,981) <0,0001 1,647 (1,010–2,685) = 0,045
a p- value were calculated using glm link(log) fam(Poisson)
b adjusted model by sex and age
https://doi.org/10.1371/journal.pone.0254440.t003
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Laboratory results in PWS
Blood samples were obtained from 122 PWS to measure cholesterol, VLDL, HDL, triglycer-
ides, glycosylated hemoglobin (HbA1c), fasting glucose and hematocrit. Of these,
HbA1c > 6% was detected in 28 (22.9%), intermediate cholesterol levels (between 200–239
mg/dl) were found in 40 (32.8%), and high cholesterol levels (> 240mg/dl) were found in 35
(28.7%). Borderline high triglycerides (150–199 mg/dl) were present in 29 (23.8%), a high level
(200–499 mg/dl) in 15 (12.3%) and very high level (>500 mg/dl) in 2 (1.6%). Total cholesterol/
HDL cholesterol ratios were outside of normal ranges in 25 males (20.5%) and 32 females
(26.2%); LDL cholesterol/HDL cholesterol ratios were outside of normal ranges in 47 males
(38.5%) and 35 females (28.7%). Fasting glucose levels were> 126 mg/dl in 12/122 (9.4%), and
low hematocrit levels (below 38%) were present in 20/122 individuals (16.4%).
Discussion
Although stroke is preventable, and international efforts, such as MONICA [23] and INTER-
STROKE [24], were performed to reduce stroke risk factors, in the past 3 decades our study is
only the second wide-scale neuroepidemiological study of stroke in a rural setting (Tumbes,
Peru) and the first involving >20,000 inhabitants [3]. In this population-based study, the
crude prevalence of stroke survival was 7.05/1,000 in rural Peru—higher than in other commu-
nity-based studies in South America (Bolivia 1.74/1,000 [6], Ecuador 3.6/1,000 [3], Colombia
4.7/1,000 [25]), Central America (Honduras 3.6/1,000 [26]) and África (Southern Nigeria 1.63/
1,000 [27]); slightly higher than in Cusco (Peru, Highland) 6.2/1,000 [5] and lower than in
Asia (China 66.90/1,000 [13] and 15.96/1000 [28]) and other African studies (Nigeria, Delta
Region 13.31/1,000 [29] and 8.51/1,000 [30]). We also detected a worrisome high prevalence
of stroke in people younger than 44 years (3.58/1,000 inhabitants).
Stroke incidence rates were higher than those reported in previous studies in Peru (13/
100,000 person/year) and Bolivia (35/100,000 person/year), slightly lower than in Colombia
(89/100,000 person/year) [3], and lower than developing countries in Central/Eastern Europe
(276.2/100,000 person/year) [31] and rural China (298/100,000 person/year)—a region with
one of the highest burdens of stroke [28]. Higher incidence rates have been related to low edu-
cation and socioeconomic status [28].
If we added the 25 premature stroke deaths to the 157 PWS in our study (182 total PWS), the
real prevalence of stroke would have been 8/1000 inhabitants—higher than reported in other
prior studies. Limited access to health care, low educational levels, ethnic factors, among other
underreported or unidentified factors, may all play a role in Peru’s high prevalence of stroke in
rural areas. In terms of numbers, 251,520 inhabitants in Peru reported a stroke event (All
Tumbes Region), higher than reported in a previous epidemiological study in Peru (186,000
inhabitants). Other factors specific to different rural areas may also increase stroke risk.
Hypertension (119/157, 75.8%) and sedentary lifestyle (138/157, 87.9%) were associated
with stroke in our study; prevalence of hypertension in PWS was similar to that reported in
studies in Latin America [3, 6, 7, 32] and Sub-Saharan Africa [33] but lower compared to Nige-
ria (92.5%) [29]. Hypertension prevalence in our population was 16%, lower compared to
Indonesia [34] and European countries (30–45%) [35]. Seventy percent of PWS who had
hypertension were poorly compliant with antihypertensive therapy, consistent with informa-
tion from other Peruvian regions [36]. Sedentary lifestyle is a public health problem worldwide
[37]; Every hour of sedentary behavior increases systolic and diastolic blood pressure by 0.06
mmHg and 0.2mmHg, respectively [38]; including a dynamic educational component in
regional non-communicable disease programs to promote healthier lifestyles in elementary
schools, popular-dining places (comedores Populares), and rural households could be a
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strategy for encouraging physical activity and help decrease high blood pressure. Improving
the patient-health center relationship is essential for empowering the patient on the impor-
tance of effective treatment compliance and lifestyle changes to control hypertension and
avoid a stroke event.
Twenty-five of 95 deaths reported in our study were due to post-stroke complications.
Although our study was not designed to evaluate mortality, our crude mortality rate (1,576/
100,000 deaths per year) in people suspected of stroke was extremely high compared to mortal-
ity rates from stroke in China (159/100,000 deaths per year) [28] or the US (37.6/100,000 deaths
per year) [39]. Low socioeconomic and educational levels and social inequality have been asso-
ciated with higher mortality rates in other poor regions of Latin America and the Caribbean [2].
This study supported Saposnik and Del Brutto’s hypothesis that a high incidence of stroke
is associated with a high risk of mortality during the acute stroke phase [3]. Although a signifi-
cant proportion of the rural population had access to free health care through the Peruvian
government’s SIS (Sistema Integral de Salud) program, many PWS sought initial evaluation
through "sobadores" (people who massage the part of the body affected by a stroke) and only
later sought traditional care at the hospital outpatient clinic. This particular behavior has been
found in other neurological research in this area [40]. This and other cultural idiosyncrasies
may delay seeking medical treatment, and future research should examine how improving the
patient-health-care provider interaction could reduce such delay. A comprehensive primary-
care training campaign to improve education for patients regarding stroke symptoms, preven-
tion, and treatment, as well as optimal cardiovascular health measures, might encourage future
stroke patients to seek their first care through hospitals.
Our study’s strengths included the support of 20 GPs from local health centers to recruit
and enroll patients, and 8 neurologists to confirm stroke diagnoses. We demonstrated that it is
possible to apply the WHO’s suggestions and accomplish stroke detection at the primary-care
level, where the main health response is primary-care and prevention [41]. This strategy could
be replicable by chronic disease programs inside other ministries of health.
Our study had some limitations. Neuroimaging was limited to CT, which is less sensitive
than MRI for detecting stroke. Also, we did not perform EKG to assess for cardiac pathology.
It is possible that stroke was under-represented as a cause of death, as “sudden deaths” caused
by cardiovascular or cerebrovascular disease, are not verified by pathologic evaluation and are
often reported as “cardiorespiratory arrest” on death certificates [42]. Epidemiological research
with standardized methodology to identify factors associated with high mortality rates in
stroke is urgently needed for a more accurate assessment of the burden and characteristics of
stroke mortality in Peru.
Conclusion
Stroke prevalence at sea level in Peru was higher than prior epidemiological studies from
South America, but lower than in industrialized countries where the decrease in mortality of
stroke has increased survival. High mortality in PWS compared to other rural settings could
be due to a lack of care-seeking at primary care levels. Although stroke is the main cause for
disability, it will remain a neglected chronic disease, especially in rural settings, until health
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